<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137725">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01711281</url>
  </required_header>
  <id_info>
    <org_study_id>CR010</org_study_id>
    <nct_id>NCT01711281</nct_id>
  </id_info>
  <brief_title>Monitoring of Hemodynamics in Heart Failure Patients by Intracardiac Impedance Measurement</brief_title>
  <acronym>BIODetectHFII</acronym>
  <official_title>Monitoring of Hemodynamics in Heart Failure Patients by Intracardiac Impedance Measurement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart Failure (HF) is one of the most frequent diagnoses upon hospitalization and is a major
      cause of death. Cardiac resynchronization therapy (CRT) using an implantable device for
      synchronous bi-ventricular stimulation leads to improvement of hemodynamic parameters,
      physical capacity and quality of life. A continuous measurement of the left-ventricular
      volume would provide information about heart performance and could be used for both heart
      failure monitoring and optimization of CRT-therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Intra-indivudual correlation coefficient r between stroke volume (SV) and stroke impedance (SZ).</measure>
    <time_frame>Month 2</time_frame>
    <safety_issue>No</safety_issue>
    <description>SV will be assessed using Echo Doppler Ao-VTI (Aortic velocity time integral). SZ will be measured in parallel using intracardiac impedance measurement. The parameters will be assessed during a sequential measurement being conducted in month 2 of the observational period. Hemodynamic changes will be actively provoked using the CRT-D system for overdrive-pacing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra-individual correlation coefficient r between left-ventricular end-systolic volume (LVESV) and left-ventricular end-systolic impedance (LVESZ).</measure>
    <time_frame>Month 2</time_frame>
    <safety_issue>No</safety_issue>
    <description>LVESV will be assessed using echo Biplane Simpson's method. LVESZ will be measured using the intracardiac impedance measurement. The parameters will be assessed during a sequential measurement being conducted in month 2 of the observational period. Hemodynamic changes will be actively provoked using the CRT-D system for overdrive-pacing.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Intra-individual correlation coefficient r between stroke volume (SV) and stroke impedance (SZ).</measure>
    <time_frame>Month 2</time_frame>
    <safety_issue>No</safety_issue>
    <description>SV will be assessed using a non-invasive blood pressure measurement device. SZ will be measured using the intracardiac impedance measurement.The parameters will be assessed during a sequential measurement being conducted in month 2 of the observational period. Hemodynamic changes will be actively provoked using the CRT-D system for overdrive-pacing.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Intracardiac Impedance Measurement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intracardiac Impedance Measurement Algorithm (integrated in CRT-D device)</intervention_name>
    <arm_group_label>Intracardiac Impedance Measurement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  De novo CRT-patients

          -  Planned implantation with a Lumax 740 HF-T device, a bipolar LV-lead and a true
             bipolar RV-lead

          -  NYHA class II or III

          -  QRS ≥ 150 ms

          -  LVEF between 15% and 35%

          -  LVEDD ≥ 55 mm

          -  Evaluable echo measurements

        Exclusion Criteria:

          -  Persistent or permanent atrial fibrillation

          -  Heart surgery within the previous 3 months or planned for the time of study
             participation; post-heart transplantation or listed for heart transplantation

          -  Non-ambulatory patients

          -  Chronic renal dialysis

          -  Life expectancy less than 1 year due to a non-cardiac disease

          -  Age &lt; 18 years and/or limited contractual capability

          -  Addiction to alcohol, medical drugs or illegal drugs

          -  Pregnant or breast-feeding women

          -  Participation in another clinical trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Sogaard, MD, PhD, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Aalborg University, Aalborg University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Klaus-Jürgen Gutleben, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Herz- und Diabeteszentrum NRW, Bad Oeynhausen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Helmuth Wagner, Dr.</last_name>
    <phone>+49 30 68905 1302</phone>
    <email>helmuth.wagner@biotronik.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aalborg Sygehus, Kardiologisk Afdeling</name>
      <address>
        <city>Aalborg</city>
        <zip>DK-9100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ole Eschen, MD, PhD</last_name>
      <phone>+45 99324914</phone>
      <email>oe@rn.dk</email>
    </contact>
    <investigator>
      <last_name>Ole Eschen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aarhus Universitetshospital, Hjertemedicinsk Afdeling B</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens C Nielsen, MD, PhD, Prof.</last_name>
      <phone>+45 78450999</phone>
      <email>jenniels@rm.dk</email>
    </contact>
    <investigator>
      <last_name>Jens C Nielsen, MD, PhD, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gentofte Hospital, Department P</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niels E Bruun, MD, PhD, DMSc</last_name>
      <phone>+45 39777947</phone>
      <email>nibru@geh.regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Niels E Bruun, MD, PhD, DMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital, Hjertemedicinsk Afdeling B</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens B Johansen, MD, PhD</last_name>
      <phone>+45 66113333</phone>
      <email>brock@dadlnet.dk</email>
    </contact>
    <investigator>
      <last_name>Jens B Johansen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus-Jürgen Gutleben, MD, PhD</last_name>
      <phone>+49 5731971327</phone>
      <email>kjgutleben@hdz-nrw.de</email>
    </contact>
    <investigator>
      <last_name>Klaus-Jürgen Gutleben, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charité Campus Virchow-Klinik, Medizinische Klinik mit Schwerpunkt Kardiologie</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mattias J Roser, MD, PhD</last_name>
      <phone>+49 30450553741</phone>
      <email>mattias.roser@charite.de</email>
    </contact>
    <investigator>
      <last_name>Mattias J Roser, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Brandenburg, Immanuel Klinikum</name>
      <address>
        <city>Bernau</city>
        <zip>16321</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Butter, MD, PhD, PD</last_name>
      <phone>+49 3338694610</phone>
      <email>c.butter@immanuel.de</email>
    </contact>
    <investigator>
      <last_name>Christian Butter, MD, PhD, PD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Bielefeld Mitte</name>
      <address>
        <city>Bielefeld</city>
        <zip>33604</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Stellbrink, MD, PhD, Prof.</last_name>
      <phone>+49 521 5813401</phone>
      <email>christoph.stellbrink@sk-bielefeld.de</email>
    </contact>
    <investigator>
      <last_name>Christoph Stellbrink, MD, PhD, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus</name>
      <address>
        <city>Bielefeld</city>
        <zip>Bielefeld</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carsten W. Israel, PD Dr. med.</last_name>
      <phone>+49 521 - 77277525</phone>
      <email>carsten.israel@evkb.de</email>
    </contact>
    <investigator>
      <last_name>Carsten W. Israel, PD. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover, Klinik für Kardiologie und Angiologie</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanno HH Oswald, MD, PhD, PD</last_name>
      <phone>+49 5115326523</phone>
      <email>oswald.hanno@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Hanno HH Oswald, MD, PhD, PD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kliniken Maria Hilf GmbH, Innere Medizin II, Klinik für Kardiologie</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41063</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Istvan Szendey, MD, PhD,</last_name>
      <phone>+49 21618920</phone>
      <email>istvan.szendey@mariahilf.de</email>
    </contact>
    <investigator>
      <last_name>Istvan Szendey, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München - Grosshadern</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi L. Estner, PD Dr. med.</last_name>
      <phone>+49 89 70956036</phone>
      <email>heidi.estner@med.uni-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Heidi L. Estner, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Havellandklinik Nauen</name>
      <address>
        <city>Nauen</city>
        <zip>16461</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martin Stickburger, PD Dr. med</last_name>
      <phone>+49 (0) 3321 42 1100</phone>
      <email>martin.stockburger@havelland-kliniken.de</email>
    </contact>
    <investigator>
      <last_name>Martin Stockburger, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Reinbek St. Adolf-Stift, Innere Abt. Kardiologie</name>
      <address>
        <city>Reinbek</city>
        <zip>21465</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herbert Nägele, MD, PhD, Prof.</last_name>
      <phone>+49 4072805158</phone>
      <email>herbert-naegele@krankenhaus-reinbek.de</email>
    </contact>
    <investigator>
      <last_name>Herbert Nägele, MD, PhD, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik I, Medizinische Intensiv- und Notfallmedizin</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oliver Ritter, MD, PhD, Prof.</last_name>
      <phone>+49 931 20139033</phone>
      <email>Ritter_O@klinik.uni-wuerzburg.de</email>
    </contact>
    <investigator>
      <last_name>Oliver Ritter, MD, PhD, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Univesitaria, Ospedali Riuniti Umberto I- G.M. Lancisi- G. Salesi</name>
      <address>
        <city>Ancona</city>
        <zip>60126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alessandro Capucci, Prof. Dr.</last_name>
      <phone>+39 71 5965440</phone>
      <email>a.capucci@univpm.it</email>
    </contact>
    <investigator>
      <last_name>Alessandro Capucci, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Toscana G. Monasterio</name>
      <address>
        <city>Pisa</city>
        <zip>56124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcello Piacenti, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Marcello Piacenti, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <zip>2333 ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lieselotte van Erven, MD, PhD</last_name>
      <phone>+31 715262020</phone>
      <email>l.van_erven@lumc.nl</email>
    </contact>
    <investigator>
      <last_name>Lieselotte van Erven, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tamás Szili-Török, Dr. med.</last_name>
      <phone>+31 (0) 6 33330605</phone>
      <email>t.szilitorok@erasmusmc.nl</email>
    </contact>
    <investigator>
      <last_name>Tamás Szili-Török, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Isala Klinieken, Hospital de Weezenlanden, Department of Cardiology</name>
      <address>
        <city>Zwolle</city>
        <zip>8011 JW</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter-Paul HM Delnoy, MD, PhD</last_name>
      <phone>+31 384247025</phone>
      <email>p.p.h.m.delnoy@isala.nl</email>
    </contact>
    <investigator>
      <last_name>Peter-Paul HM Delnoy, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>December 18, 2013</lastchanged_date>
  <firstreceived_date>October 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Implantable Cardioverter-Defibrillator</keyword>
  <keyword>Intracardiac Impedance Measurement</keyword>
  <keyword>Cardiac Resynchronization Therapy</keyword>
  <keyword>Home Monitoring</keyword>
  <keyword>Reverse Remodeling</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
